SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a ...

Columnist Susan Payrovi credits hand weakness and MS with the pivots in her medical career that now allow her to focus on ...

Disease-modifying therapies for MS that prevent brain volume loss are linked to reduced long-term disability, new data show.

Understand brain fog in progressive MS, its causes, and treatments. Learn self-help strategies to manage daily life, improve ...

Clinicians and health system leaders met in Portland, Oregon, on October 21, 2025, to discuss the evolving options for treating Alzheimer disease and multiple sclerosis.

Hydrotherapy significantly improved balance and reduced fatigue in MS patients compared to standard physiotherapy, enhancing daily function and energy levels. The study used the Modified Fatigue ...

Artificial intelligence (AI) workloads are very different from those traditionally run inside of data centers, and while the current infrastructure can accommodate those needs, there is a constant ...

For years, Selma Blair battled unexplained pain and crippling fatigue while doctors dismissed her symptoms. Blair revealed that despite experiencing symptoms since childhood, her multiple sclerosis ...

Researchers have identified two compounds, K102 and K110, that could repair the nerve damage from multiple sclerosis. These drugs help regenerate the protective myelin sheath and balance immune ...

Poster: LX9211, a Novel AAK1 Inhibitor, Alleviates Pain in Preclinical Models of Chemotherapy-induced Neuropathic Pain and Multiple Sclerosis Date: Saturday, September 6, 2025 Time: 8:30 a.m. – 6:00 p ...